Price and Volume Buzzers for Feb 23: Trident, Aegis Vopak, Blue Jet Jump Up to 10%


By Dalal Street Investment Journal (DSIJ)

Summary:


Trident, Aegis Vopak Terminals, and Blue Jet Healthcare were among the top gainers in the Nifty 500 on February 23. Stock-specific triggers drove the rally, with higher trading volume. Trident gained from the reduction of US tariffs despite weak Q3FY26 results. Aegis Vopak rose on strong earnings and expansion. Blue Jet rebounded after a recent correction, despite weak quarterly performance.

Trident, Aegis Vopak, Blue Jet jump up to 10%: Here’s why

Trident

Trident, one of India’s leading textile manufacturers, is among the top gainers in the Nifty 500. Its share price rose by around 5% following the US's tariff reduction. The strike down of tariffs by the U.S. Supreme Court also provided a boost to textile stocks in India.

On February 23, Trident's share price surged amid robust volume. Volume jumped over 2x to 3.41 crore shares on the NSE as compared to the 30-days average of 1.42 crore shares. This move came as the company reported muted financials in Q3FY26.

Total income decreased by 5.2% year-on-year to ₹1,594.9 crore in Q3FY26. EBITDA declined by 30.5% to ₹159.3 crore. The margin contracted by 363 bps to 9.99%, leading to an 44.77% decline in net profit to ₹44.2 crore. The optimism is that, with the reduced tariff, even at 15% below the previous 50% and 18%, the US market, from where it generates over 40% of revenue. 

Aegis Vopak Terminals

With 9.3% gain, Aegis Vopak, the liquefied petroleum gas storage operator, is another stock leading the list of gainers. This surge also followed a jump in trading volume to 35.6 lakh, compared with the 30-day average of 13.4 lakh. This move followed the company's strong financial performance in Q3FY26.

In Q3FY26, revenue from operations surged by 22.3% year-on-year to ₹197.5 crore. EBITDA rose by 23% to ₹145.9 crore, while margins declined by 43 bps to 73%. Net profit surged 62.7% to ₹61.5 crore. As of Q3FY26, the order book stood at ₹743.4 crore. The company announced the construction of India’s first independent 36,000-MT Ammonia Terminal by Q1 FY27.

Blue Jet Healthcare Ltd

Trade

391.435.54 (9.98 %)

Updated - 23 February 2026
391.40day high
DAY HIGH
357.60day low
DAY LOW
3351292
VOLUME (BSE)

Blue Jet Healthcare

With a 9.9% gain, Blue Jet, a CDMO player, is the top gainer. This surge also followed an over 4X jump in trading volume to 27.83 crore, compared with the 30-day average of 5.7 lakh. The move comes after its share price declined by almost 20% over the last month, following weak Q3FY26 results.

In Q3FY26, revenue fell by 39.6% year-on-year to ₹192.4 crore, driven by a 72.6% decline in revenue from pharma intermediaries and API. EBITDA declined by 62.2% to ₹46.9 crore, down from ₹124 crore in the same period last year. Margins fell by 1460 bps to 24.4%. The company's net profit decreased to ₹40.2 crore, down from ₹99 crore.

Conclusion

Overall, the sharp price and volume action reflect stock-specific triggers. While Trident rallied on a reduction in US tariffs, Aegis gained on strong Q3FY26 financial performance, and Blue Jet rebounded after a correction.

About the Author

SEBI Registered Research Analyst (INH000006396).


Founded in 1986, Dalal Street Investment Journal (DSIJ) brings decades of experience in India’s equity markets. DSIJ's research combines fundamental analysis with price action, guided by disciplined risk management and capital preservation. They follow a structured, data-driven approach designed to help investors and traders make informed decisions beyond short-term market noise. 

Published Date : 23 Feb 2026

Disclaimer :

Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.

The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes.

The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.

Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.

BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.


Content Partner - Dalal Street Investment Journal Wealth Advisory Private Limited



This article is for educational purposes only and should not be considered investment advice. Market investments are subject to risks. DSIJ Wealth Advisory Private Limited is a SEBI-registered Research Analyst (Reg. No: INH000006396) and Investment Adviser (Reg. No: INA000001142). Please consult your financial adviser before investing. 

[ Read More ]

For more disclaimer, check here : https://www.bajajbroking.in/disclaimer

Read More Blogs

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

10 lakh+ Users

icon-with-text

4.8 App Rating

icon-with-text

4 Languages

icon-with-text

₹7,300+ Cr MTF Book

icon-with-text